Glial cell line-derived neurotrophic growth factor inhibits apoptotic death of postnatal substantia nigra dopamine neurons in primary culture

Journal of Neurochemistry

Volumn 71, Issue 2, 1998, Pages 517-525

  Burke, Robert E ^a,b   Antonelli, Megan ^a   Sulzer, David ^a  

^a College of Physicians and Surgeons ^*  (United States)

^b Box 67 ^*  (United States)

Author keywords

Apoptosis; Dopamine; Glial cell line derived neurotrophic factor; Parkinson's disease; Substantia nigra; Trophic factors

Indexed keywords

GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; DOPAMINERGIC NERVE CELL; EMBRYO DEVELOPMENT; GLIA CELL; GROWTH REGULATION; NERVE GROWTH; NONHUMAN; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

ANIMALIA;

EID: 0031783647     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1998.71020517.x     Document Type: Article

References (41)

1. Alexi T. and Hefti F. (1993 ) Trophic actions of transforming growth factor α on mesencephalic dopaminergic neurons developing in culture. Neuroscience 55, 903-918.
2. Barde Y. A. (1989) Trophic factors and neuronal survival. Neuron 2, 1525-1534.
3. Beck K. D., Valverde J., Alexi T., Poulsen K., Moffat B., Vandien R. A., Rosenthal A., and Hefti F. (1995) Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature 373, 339-341.
4. Blum M. and Weickert C. S. (1995) GDNF mRNA expression in normal postnatal development, aging, and in weaver mutant mice. Neurobiol. Aging 16, 925-929.
5. Bowenkamp K. E., Huffman A. F., Gerhardt G. A., Henry M. A., Biddle P. T., Hoffer B. J., and Granholm A.-C. E. (1995) Glial cell line-derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons. J. Comp. Neural. 355, 479-489.
6. Casper D., Mytilineou C., and Blum M. (1991) EGF enhances the survival of dopamine neurons in rat embryonic mesencephalon primary cell culture. J. Neurosci. Res. 30, 372-381.
7. Choi-Lundberg D. L. and Bohn M. C. (1995) Ontogeny and distribution of glial cell line-derived neurotrophic factor (GDNF) mRNA in rat. Dev. Brain Res. 85, 80-88.
8. Clarke P. G. H. (1985) Neuronal death in the development of the vertebrate nervous system. Trends Neurosci. 8, 345-349.
9. Cubells J. F., Rayport S., Rajendran G., and Sulzer D. (1994) Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress. J. Neurosci. 14, 2260-2271.
10. Gash D. M., Zhang Z. M., Ovadia A., Cass W. A., Yi A., Simmerman L., Russell D., Martin D., Lapchak P. A., Collins F., Hoffer B. J., and Gerhardt G. A. (1996) Functional recovery in parkinsonian monkeys treated with GDNF. Nature 380, 252-255.
11. Hou J.-G. G., Lin L.-F. H., and Mytilineou C. (1996) Glial cell line-derived neurotrophic factor exerts neurotrophic effects on dopaminergic neurons in vitro and promotes their survival and regrowth after damage by 1-methy1-4-phenylpyridinium. J. Neurochem. 66, 74-82.
12. Hyman C., Hofer M., Barde Y. A., Juhasz M., Yancopoulos G. D., Squinto S. P., and Lindsay R. M. (1991) BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 350, 230-232.
13. Janec E. and Burke R. E. (1993) Naturally occurring cell death during postnatal development of the substantia nigra of the rat. Mol. Cell. Neurosci. 4, 30-35.
14. Kalsbeek A., Voorn P., and Buijs R. M. (1992) Development of dopamine-containing systems in the CNS, in Handbook of Chemical Neuroanatomy, Vol. 10: Ontogeny of Transmitters and Peptides in the CNS (Bjorklund A., Hokfelt T., and Tohyama M., eds), pp. 63-112. Elsevier Science, Amsterdam.
15. Kelly W. J. and Burke R. E. (1996) Apoptotic neuron death in rat substantia nigra induced by striatal excitotoxic injury is developmentally dependent. Neurosci. Lett. 220, 85-88.
16. Kessler J. A., Ludlam W. H., Freidin M. M., Hall D. H., Michaelson M. D., Spray D. C., Dougherty M., and Batter D.K. (1993) Cytokine induced programmed death of cultured sympathetic neurons. Neuron 11, 1123-1132.
17. Knüsel B., Michel P. P., Schwaber J. S., and Hefti F. (1990) Selective and nonselective stimulation of central cholinergic and dopaminergic development in vitro by nerve growth factor, basic fibroblast growth factor, epidermal growth factor, insulin and the insulin-like growth factors I and II. J. Neurosci. 10, 558-570.
18. Lin L.-F. H., Doherty D. H., Lile J. D., Bektesh S., and Collins F. (1993) GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260, 1130-1132.
19. Macaya A., Munell F., Gubits R. M., and Burke R. E. (1994) Apoptosis in substantia nigra following developmental striatal excitotoxic injury. Proc. Natl. Acad. Sci. USA 91, 8117-8121.
20. Marti M. J., James C. J., Oo T. F., Kelly W. J., and Burke R. E. (1997) Early developmental destruction of terminals in the striatal target induces apoptosis in dopamine neurons of the substantia nigra. J. Neurosci. 17, 2030-2039.
21. Mena M. A., Davila V., and Sulzer D. ( 1997) Neurotrophic effects of L-DOPA in postnatal midbrain dopamine neuron/cortical astrocyte cocultures. J. Neurochem. 69, 1398-1408.
22. Moore M. W., Klein R. D., Farinas I., Sauer H., Armanini M., Phillips H., Reichardt L. F., Ryan A. M., Carver-Moore K., and Rosenthal A. (1996) Renal and neuronal abnormalities in mice lacking GDNF. Nature 382, 76-79.
23. Oo T. F. and Burke R. E. (1997) The time course of developmental cell death in phenotypically defined dopaminergic neurons of the substantia nigra. Dev. Brain Res. 98, 191-196.
24. Pichel J. G., Shen L., Sheng H. Z., Granholm A.-C., Drago J., Grinberg A., Lee E. J., Huang S. P., Saarma M., Hoffer B. J., Sariola H., and Westphal H. (1996) Defects in enteric innervation and kidney development in mice lacking GDNF. Nature 382, 73-76.
25. Pothos E., Desmond M., and Sulzer D. (1996) L-3,4-Dihydroxyphe-nylalanine increases the quantal size of exocytic dopamine release in vitro. J, Neurochem. 66, 629-636.
26. Pothos E. N., Davila V., and Sulzer D. (1997) Glial-derived neurotrophic factor increases quantal size in midbrain dopamine neurons. Sac. Neurosci. Abstr. 23, 1173.
27. Poulsen K. T., Armanini M. P., Klein R. D., Hynes M. A., Phillips H. S., and Rosenthal A. (1994) TGF β2 and TGF β3 are potent survival factors for midbrain dopaminergic neurons. Neuron 13, 1245-1252.
28. Przedborski S., Khan U., Kostic V., Carlson E., Epstein C. J., and Sulzer D. (1996) Increased Superoxide dismutase activity improves survival of cultured postnatal midbrain neurons. J. Neurochem. 67, 1383-1392.
29. Rayport S. and Sulzer D. (1995) Visualization of antipsychotic binding to living mesolimbic neurons reveals D2 receptor mediated, acidotropic and lipophilic components. J. Neurochem. 65, 691 -703.
30. Rayport S., Sulzer D., Shi W. X., Sawasdikosol S., Monaco J., Batson D., and Rajendran G. (1992) Identified postnatal mesolimbic dopamine neurons in culture morphology and electrophysiology. J. Neumsci. 12, 4264-4280.
31. Sanchez M. P., Silos-Santiago I., Frisen J., He B., Lira S. A., and Barbacid M. (1996) Renal agenesis and the absence of enteric neurons in mice lacking GDNF. Nature 382, 70-73.
32. Sauer H., Rosenblad C., and Bjorklund A. (1995) Glial cell line-derived neurotrophic factor but not transforming growth factor β3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesion. Proc. Natl. Acad. Sic. USA 92, 8935-8939.
33. Schaar D. G., Sieber B. A., Dreyfus C. F., and Black I. B. (1993) Regional and cell specific expression of GDNF in rat brain. Exp. Neurol. 124, 368-371.
34. Specht L. A., Pickel V. M., Joh T. H., and Reis D. J. (1981) Light-microscopic immunocytochemical localization of tyrosine hydroxylase in prenatal brain. I. Early ontogeny. J. Comp. Neurol. 199, 233-253.
35. Stromberg I., Bjorklund L., Johansson M., Tomac A., Collins F., Olson L., Hoffer B., and Humpel C. (1993) Glial cell line derived neurotrophic factor is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo. Exp. Neurol. 124, 401-412.
36. Sulzer D., Maidment N.T., and Rayport S. (1993) Amphetamine and other weak bases act to promote reverse transport of dopamine in ventral midbrain neurons. J. Neurochem. 60, 527-535.
37. Sulzer D., St. Remy C., and Rayport S. (1996) Reserpine inhibits amphetamine action in ventral midbrain culture. Mol Pharmacol. 49, 338-342.
38. Tepper J. M., Damlama M., and Trent F. (1994) Postnatal changes in the distribution and morphology of rat substantia nigra dopaminergic neurons. Neuroscience 60, 469-477.
39. Tomac A., Lindqvist E., Lin L.-F. H., Ogren S. O., Young D., Hoffer B. J., and Olson L. ( 1995a) Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature 373, 335-339.
40. Tomac A., Widenfalk J., Lin L. H., Kohno T., Ebendal T., Hoffer B. J., and Olson L. ( 1995b) Retrograde axonal transport of glial cell line-derived neurotrophic factor in the adult nigrostriatal system suggests a trophic role in the adult. Proc. Natl. Acad. Sci. USA 92, 8274-8278.
41. Treanor J. J. S., Goodman L., deSauvage F., Stone D. M., Poulsen K. T., Beck C. D., Gray C., Armanini M. P., Pollock R. A., Hefti F., Phillips H. S., Goddard A., Moore M. W., Buj-Bello A., Davies A. M., Asai N., Takahashi M., Vandlen R., Henderson C. E., and Rosenthal A. (1996) Characterization of a multicomponent receptor for GDNF. Nature 382, 80-83.